DERMATOMYOSImS was originally and independently described and named in 1887, by three persons: Hepp-pseudotrichinosis; Wagneracute polymyositis; and Unverricht-acute progressive polymyositis. Unverricht later attached -the name of Dermatomyositis to the condition, and though in the absence of cutaneous symptoms the term polymyositis is proper (Wedgewood, Cook and Cohen, 1953) , the full term of dermatomyositis is preferable as serving to distinguish this variety of polymyositis from all others. The acute form is still known as the Wagner-Unverricht type (Degos) .
First reports of the co-existence of dermatomyositis and visceral cancer came from Stertz (1916) , Gottron (1931) , and Bezecny (1935) Grace and Dao (1959) in a patient with carcinoma of breast, and they too postulated that sensitivity played a role in the genesis of dermatomyositis.
But dermatomyositis could also represent a failure of immunity. Burnet (1961) considered that the first step in evolution of the immune process lay in selfrecognition and the ability to delete somatic mutant (malignant) cells; and he (Burnet, 1964) 
